Ethosuximide Solution
Product Images NDC 0121-0670

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 0121-0670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ethosuximide 01)

Chemical structure of ethosuximide, depicting its molecular arrangement with characteristic functional groups and bonds as shown in the image.*

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Label for Ethosuximide Oral Solution USP 250 mg/5 mL, a human prescription oral solution by PAI Holdings, LLC dba PAI Pharma. The label shows the NDC 0121-0670-16 and specifies a 16 fl oz (473 mL) container. Storage and pharmacist dispensing instructions are provided, along with a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.